and that those whose insurance doesn’t cover the drug can get $500 off its $1,350 list price for up to a year. As with Wegovy ...
The FDA recently approved Zepbound, a weekly injectable drug targeted to treat obesity. The medication contains tirzepatide, the same active ingredient that is also present in the diabetes drug ...
The FDA has approved PureTech Health’s ‘space occupying ... This would give it an edge on Novo’s obesity drug Saxenda (liraglutide), whose possible side effects include nausea, diarrhoea ...
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...
Medpage Today on MSN12d
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1DThe FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once ...
Novo Nordisk is celebrating the FDA approval of its ... by Novo Nordisk as a daily pill called Rybelsus for diabetes, but that version isn't approved as an obesity treatment yet although a phase ...
The U.S. Food and Drug Administration (FDA) has approved seven medications for ... Adults and children over 12 years old living with obesity are eligible to take this drug. Like Saxenda, you ...
Rhythm Pharmaceuticals’ RYTM shares gained 8.4% on Aug. 26 after announcing the FDA ... new drug application (sNDA) for its only marketed drug, Imcivree (setmelanotide), to treat obesity ...
The U.S. Food and Drug Administration (FDA) approved the drug for weight control ... The drug has caused a lot of sensation as it attacks obesity. It was found that people on the drug ate less.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback